Editorial: Linking cellular metabolism to hematological malignancies, volume II

Zhuojun Liu; Jian Yu; Zhizhuang Joe Zhao; Hubing Shi; Manoj Kumar Kashyap

doi:10.3389/fonc.2024.1387249

Editorial: Linking cellular metabolism to hematological malignancies, volume II

Front Oncol. 2024 Apr 9:14:1387249. doi: 10.3389/fonc.2024.1387249. eCollection 2024.

Authors

Zhuojun Liu¹, Jian Yu¹, Zhizhuang Joe Zhao², Hubing Shi³, Manoj Kumar Kashyap⁴

Affiliations

¹ Key Laboratory of Biomechanics and Mechanobiology, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.
² Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
³ Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China.
⁴ Amity Stem Cell Institute, Amity Medical School, Amity University Haryana, Gurugram, Haryana, India.

No abstract available

Keywords: RNA-Seq; Reactive oxygen active (ROS); ferroptosis; leukemia; lipid reprogramming; multiple myeloma.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Financial support from the Indian Council of Medical Research (ICMR), New Delhi (sanction #: 5/13/55/2020/NCD-III) to MK is thankfully acknowledged. This work was supported by the Academic Excellence Foundation of BUAA for PhD Students (BY2010134).